Home / News / FDA Approve Perrigo Generic Version of BenzaClin® Pump Topical Gel

FDA Approve Perrigo Generic Version of BenzaClin® Pump Topical Gel

Perrigo announced that it has received U.S.FDA approval for the generic version of Valeant Pharmaceutical International, Inc.’s BenzaClin® Pump Topical Gel. BenzaClin® Pump Topical Gel (clindamycin phosphate 1% and benzoyl peroxide 5%) is indicated for the topical treatment of acne vulgaris.

Combined generic and branded sales for the twelve months ending February 2016 were $79 million.

Perrigo’s Chief Executive Officer John T. Hendrickson stated, “This Rx product approval and launch provide our customers with convenient, cost effective technologies like the BenzaClin® Pump.

About Abhiram

Profile photo of Abhiram

Check Also

c

Sandoz EGALITY trial result of biosimilar etanercept show equivalent efficacy to originator product

Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced results from …

Leave a Reply

Your email address will not be published. Required fields are marked *